No Data
SymbolStock Name
PriceChg% ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D % Chg10D % Chg20D % Chg60D % Chg120D % Chg250D % Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
Watchlist
No Data
Telo Genomics Receives Intellectual Property Ontario Program Approval
Telo Genomics Expands Its Strategic Collaboration With Mayo Clinic
Telo Genomics' Myeloma Test Accepted as Lab Developed Test by College of American Pathologists
Telo Genomics Receives Accreditation From College of American Pathologists
Telo Genomics' MRD Clinical Trial Expands Into Multi-Center Trial; Shares up 9.5%
Telo Genomics Initiates MRD Clinical Trial for Multiple Myeloma Patients